HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Ali Dodge-Khatami René Prêtre Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dodge-Khatami, A. Articles by Bauersfeld, U. Search for Related Content PubMed PubMed Citation Articles by Dodge-Khatami, A. Articles by Bauersfeld, U.

Ann Thorac Surg 2005;80:1440-1444
© 2005 The Society of Thoracic Surgeons

---

Original article: Cardiovascular

Dual Chamber Epicardial Pacing for the Failing Atriopulmonary Fontan Patient

^a Division of Cardiovascular Surgery, University Children's Hospital Zürich, Zürich, Switzerland
^b Division of Cardiology, University Children's Hospital Zürich, Zürich, Switzerland
^c Division of Cardiovascular Surgery, University Hospital, Zürich, Switzerland

Accepted for publication March 30, 2005.

^_* Address reprint requests to Dr Dodge-Khatami, University Children's Hospital, University of Zürich, Steinwiesstrasse 75, CH-8032 Zürich, Switzerland; (Email: ali.dodge-khatami{at}kispi.unizh.ch).

BACKGROUND: The atriopulmonary Fontan circulation leads to arrhythmias, heart failure, or protein-losing enteropathy, eventually requiring conversion. In hesitant patients, we evaluated the effect of dual chamber pacing as a time-buying measure.

METHODS: Between 1997 and 2004, 9 patients (aged, 6 to 18 years) with an atriopulmonary Fontan connection and sinus node dysfunction received dual chamber epicardial pacemaker systems. Indications included refractory arrhythmias (n = 5), protein-losing enteropathy (n = 2), heart failure with effusions (n = 1), and exercise intolerance (n = 2). Data were compared between hospital discharge after pacemaker implantation and last follow-up.

RESULTS: There was no mortality or morbidity. At a follow-up of 3.3 ± 1.0 years, lead survival was 100%. Both atrial (impedance = 683 ± 40 Ohm; threshold = 0.8 ± 0.1 V at 0.5 ms; sensing P waves = 3.3 ± 0.8 mV) and ventricular (impedance = 630 ± 68 Ohm; threshold = 1.3 ± 0.3 V at 0.5 ms; sensing R waves = 8.7 ± 2.5 mV) leads retained satisfactory pacing characteristics at last control, better than those at discharge. Arrhythmias subsided in all instances and no longer required medication in 3 patients. Protein-losing enteropathy improved temporarily in 1 patient and disappeared in another. Exercise intolerance diminished, and heart failure was controlled.

CONCLUSIONS: Although most atriopulmonary Fontan circulations will need conversion with arrhythmia surgery, patients may delay out of fear. Dual chamber pacing improves single ventricle hemodynamics and can help decompensated Fontan patients. In a multiple-redo setting, a left lateral thoracotomy provides safe access and allows for quantitatively reliable and durable epicardial pacing.

This article has been cited by other articles:

				R. Pretre and U. Bauersfeld Minimally invasive implantation of a cardioverter in children J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 239 - 240. [Full Text] [PDF]